Hypertrophic cardiomyopathy. Combination of beta blockers and verapamil may be risky

BMJ. 2006 Jul 8;333(7558):97. doi: 10.1136/bmj.333.7558.97.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects*
  • Anti-Arrhythmia Agents / adverse effects*
  • Atrial Fibrillation / drug therapy*
  • Cardiomyopathy, Hypertrophic / drug therapy*
  • Drug Combinations
  • Humans
  • Risk Factors
  • Verapamil / adverse effects*

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Drug Combinations
  • Verapamil